TANGO2 related disease: management
Evidence-based neurology checklist on tango2 related disease: management: Genetic analysis Gene panel Exome sequencing Cardiac tests Magnetic resonance imaging (MRI) brain: features Muscle biopsy Other tests Treatment of crises Other treatments Acronym
Genetic analysis
- Gene panel
- Exome sequencing
Cardiac tests
Magnetic resonance imaging (MRI) brain: features
Muscle biopsy
Other tests
Treatment of crises
Other treatments
Acronym
References
- Milev MP, Saint-Dic D, Zardoui K, et al. The phenotype associated with variants in TANGO2 may be explained by a dual role of the protein in ER-to-Golgi transport and at the mitochondria. J Inherit Metab Dis 2021; 44:426-437.
- Dines JN, Golden-Grant K, LaCroix A, et al. TANGO2: expanding the clinical phenotype and spectrum of pathogenic variants. Genet Med 2019; 21:601-607.
- Hoebeke C, Cano A, De Lonlay P, Chabrol B. Clinical phenotype associated with TANGO2 gene mutation. Arch Pediatr 2021; 28:80-86.
- Mingirulli N, Pyle A, Hathazi D, et al. Clinical presentation and proteomic signature of patients with TANGO2 mutations. J Inherit Metab Dis 2020; 43:297-308.
- Schymick J, Leahy P, Cowan T, et al. Variable clinical severity in TANGO2 deficiency: case series and literature review. Am J Med Genet A 2022; 188:473-487.
- And 3 more. Subscribe to see the full list